Novartis AG logo

Novartis AG

NVS | NYSE
Chart Builder DCF Calculator
$142.53
+$1.25 (+0.88%)
At close: Sep 23, 2026, 3:43 PM ET
$142.05
-$0.48 (-0.34%)
After-hours: Sep 23, 2026, 5:29 PM ET
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 28, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
55.63B 56.05B 56.15B 56.37B 55.19B 53.22B 51.72B 49.94B 48.86B 47.73B 46.66B 47.97B 46.66B 48B 49.77B 50.2B 52.79B 53B 52.88B 52.39B 51.56B 49.88B
Cost of Revenue
14.22B 13.86B 13.63B 13.41B 13.11B 12.96B 12.83B 12.53B 12.41B 12.58B 12.47B 13.52B 13.28B 13.69B 14.55B 14.46B 15.52B 15.68B 15.87B 16.11B 15.92B 15.44B
Gross Profit
41.41B 42.19B 42.52B 42.96B 42.08B 40.26B 38.9B 37.42B 36.45B 35.16B 34.19B 34.45B 33.38B 34.31B 35.22B 35.75B 37.27B 37.31B 37.01B 36.28B 35.63B 34.45B
Operating Income
16.99B 17.12B 17.55B 17.56B 16.68B 15.83B 14.54B 13.6B 11.73B 10.52B 9.77B 9.14B 9.2B 8.62B 8.86B 9.47B 10.88B 12.13B 11.69B 11.77B 10.95B 9.82B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
15.52B 15.78B 16.35B 16.42B 15.61B 14.92B 13.64B 12.73B 10.9B 9.73B 9.12B 8.49B 8.52B 7.89B 8.04B 23.25B 24.89B 26.36B 26.14B 11.75B 10.93B 9.71B
Net Income
12.76B 13.53B 13.98B 14.39B 13.65B 12.86B 11.94B 17.6B 16.18B 15.25B 14.85B 7.84B 7.65B 7.03B 6.96B 21.8B 22.98B 24.18B 24.02B 9.81B 8.98B 7.96B
Selling & General & Admin
13.13B 13.33B 13.24B 13.31B 13.14B 12.78B 12.57B 12.51B 12.47B 12.47B 12.52B 12.82B 12.67B 13.16B 13.78B 14.01B 14.7B 14.87B 14.89B 14.83B 14.63B 14.24B
Research & Development
11.28B 11.25B 10.87B 10.88B 10.33B 9.97B 10.02B 9.75B 11.28B 11.22B 11.37B 11.25B 9.86B 10.06B 9.8B 9.77B 9.61B 9.51B 9.54B 9.46B 9.23B 9.27B
Other Expenses
16M 497M 853M 1.21B 1.93B 1.68B 1.76B 1.56B 975M 949M 531M 1.25B 1.65B 2.48B 2.78B 2.5B 2.09B 809M 895M 217M 827M 1.11B
Operating Expenses
24.42B 25.07B 24.97B 25.4B 25.4B 24.43B 24.35B 23.82B 24.72B 24.63B 24.42B 25.31B 24.18B 25.69B 26.36B 26.28B 26.39B 25.19B 25.32B 24.51B 24.68B 24.62B
Interest Expense
1.39B 1.22B 1.15B 1.12B 1.1B 1.06B 1.01B 971.11M 926.23M 896.46M 877.19M 879.69M 863.69M 849.84M 850.37M 815M 811M 810M 811M 806M 813M 832M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
38.64B 38.93B 38.6B 38.81B 38.5B 37.39B 37.18B 36.34B 37.13B 37.21B 36.89B 38.84B 37.46B 39.38B 40.91B 40.74B 41.91B 40.87B 41.19B 40.61B 40.61B 40.06B
Income Tax Expense
2.78B 2.27B 2.38B 2.04B 1.97B 2.06B 1.7B 975M 814M 622M 551M 1.09B 1.31B 1.25B 1.33B 1.7B 1.91B 2.18B 2.12B 1.93B 1.94B 1.75B
Shares Outstanding (Basic)
1.91B 1.91B 1.91B 1.93B 1.95B 1.97B 1.99B 2.01B 2.03B 2.04B 2.05B 2.06B 2.08B 2.11B 2.14B 2.17B 2.2B 2.23B 2.24B 2.24B 2.24B 2.25B
Shares Outstanding (Diluted)
1.91B 1.92B 1.93B 1.94B 1.96B 1.98B 2B 2.03B 2.05B 2.06B 2.07B 2.08B 2.1B 2.12B 2.15B 2.18B 2.21B 2.24B 2.25B 2.25B 2.26B 2.27B
EPS (Basic)
6.66 7.02 7.20 7.36 6.90 6.43 5.92 8.64 7.91 7.42 7.19 3.74 3.62 3.28 3.19 9.79 10.29 10.81 10.72 4.35 3.97 3.50
EPS (Diluted)
6.63 6.98 7.15 7.31 6.86 6.39 5.88 8.58 7.86 7.38 7.15 3.72 3.59 3.25 3.16 9.72 10.22 10.73 10.65 4.33 3.95 3.48
EBITDA
22.26B 22.4B 22.82B 22.94B 22.71B 21.88B 20.72B 19.71B 18.98B 18.33B 18.26B 17.98B 16.8B 16.25B 15.94B 30.71B 31.88B 32.99B 33.06B 18.76B 18.23B 17.29B
EBIT
16.92B 17B 17.5B 17.53B 16.71B 15.97B 14.65B 13.68B 11.81B 10.61B 9.98B 9.34B 9.36B 8.72B 8.87B 24.06B 25.7B 27.17B 26.95B 12.55B 11.74B 10.54B
Depreciation & Amortization
5.34B 5.4B 5.32B 5.4B 6B 5.91B 6.07B 6.03B 7.18B 7.72B 8.28B 8.64B 7.44B 7.54B 7.07B 6.64B 6.18B 5.82B 6.11B 6.21B 6.49B 6.75B

© 2026 bestshares.com. All rights reserved.